BR112022016428A2 - Uso de matriz extracelular placentária porcina descelularizada, estruturas porcinas e seus métodos de preparação - Google Patents

Uso de matriz extracelular placentária porcina descelularizada, estruturas porcinas e seus métodos de preparação

Info

Publication number
BR112022016428A2
BR112022016428A2 BR112022016428A BR112022016428A BR112022016428A2 BR 112022016428 A2 BR112022016428 A2 BR 112022016428A2 BR 112022016428 A BR112022016428 A BR 112022016428A BR 112022016428 A BR112022016428 A BR 112022016428A BR 112022016428 A2 BR112022016428 A2 BR 112022016428A2
Authority
BR
Brazil
Prior art keywords
porcine
extracellular matrix
structures
decellularized
preparation methods
Prior art date
Application number
BR112022016428A
Other languages
English (en)
Inventor
G Hargis Jon
Klitzke Kurt
Original Assignee
Convatec Triad Life Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Triad Life Sciences Llc filed Critical Convatec Triad Life Sciences Llc
Publication of BR112022016428A2 publication Critical patent/BR112022016428A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE MATRIZ EXTRACELULAR PLACENTÁRIA PORCINA DESCELULARIZADA, ESTRUTURAS PORCINAS E SEUS MÉTODOS DE PREPARAÇÃO. A presente invenção refere-se a estruturas porcinas que incluem uma matriz extracelular placentária porcina descelularizada. Métodos para a preparação de matriz extracelular placentária porcina descelularizada, bem como métodos de tratamento, são também proporcionados.
BR112022016428A 2020-02-21 2021-02-22 Uso de matriz extracelular placentária porcina descelularizada, estruturas porcinas e seus métodos de preparação BR112022016428A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062979731P 2020-02-21 2020-02-21
PCT/US2021/019109 WO2021168443A1 (en) 2020-02-21 2021-02-22 Porcine scaffolds and methods of preparation

Publications (1)

Publication Number Publication Date
BR112022016428A2 true BR112022016428A2 (pt) 2022-11-16

Family

ID=77391338

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022016428A BR112022016428A2 (pt) 2020-02-21 2021-02-22 Uso de matriz extracelular placentária porcina descelularizada, estruturas porcinas e seus métodos de preparação

Country Status (9)

Country Link
US (1) US20230310707A1 (pt)
EP (1) EP4106827A4 (pt)
JP (1) JP2023514702A (pt)
CN (1) CN115551566A (pt)
AU (1) AU2021222052A1 (pt)
BR (1) BR112022016428A2 (pt)
CA (1) CA3165798A1 (pt)
CO (1) CO2022011631A2 (pt)
WO (1) WO2021168443A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200810412B (en) * 2006-06-09 2010-03-31 Anthrogenesis Corp Placental niche and use thereof to culture stem cells
EP2970882B1 (en) * 2013-03-15 2018-11-28 AlloSource Cell repopulated collagen matrix for soft tissue repair and regeneration
GB201513461D0 (en) * 2015-07-30 2015-09-16 Ucl Business Plc Methods and devices for the production of decellularised tissue scaffolds
US20180303970A1 (en) * 2015-11-02 2018-10-25 VeriGraft AB Compositions and methods for healing wounds
TW201733600A (zh) * 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CN110433341A (zh) * 2019-08-29 2019-11-12 上海白衣缘生物工程有限公司 一种组织修复材料及其制备方法
CN110732042A (zh) * 2019-11-18 2020-01-31 上海白衣缘生物工程有限公司 一种皮肤生物材料
CN110975010B (zh) * 2019-11-25 2022-02-15 银丰低温医学科技有限公司 一种胎盘组织基质材料及其制备方法

Also Published As

Publication number Publication date
EP4106827A4 (en) 2024-03-20
US20230310707A1 (en) 2023-10-05
CN115551566A (zh) 2022-12-30
EP4106827A1 (en) 2022-12-28
CO2022011631A2 (es) 2022-10-21
WO2021168443A1 (en) 2021-08-26
CA3165798A1 (en) 2021-08-26
JP2023514702A (ja) 2023-04-07
AU2021222052A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
CL2017002650A1 (es) Compuestos novedosos
UY37563A (es) Aislados de bacillus y usos de los mismos
BR112015017174A2 (pt) preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico
AR077333A1 (es) Anticuerpos humanos de alta afinidad para la angiopoyetina -2 humana
UY37564A (es) Aislados de lysinibacillus y usos de los mismos
ECSP12011637A (es) Polipéptidos del factor ix modificados y usos de los mismos
UY33625A (es) Uso de ingredientes activos para controlar nematodos en cultivos resistentes a nematodos
ECSP18012793A (es) Composición y productos que comprenden células senescentes para su uso en la regeneración de tejidos
BR112014018475A8 (pt) Compostos de imidazopirrolidinona, suas formas cristalinas e seu uso, e composição farmacêutica
CL2020001797A1 (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas.
SG10201906304TA (en) Use of perfusion decellularized liver for islet cell recellularization
BR112017024013A2 (pt) composições compreendendo células tronco mesenquimatosas e seus usos
CL2020002915A1 (es) Composiciones para el tratamiento de condiciones de la piel
UY35703A (es) Anticuerpos contra el inhibidor-1 del activador de plasminógeno (pai-1) y usos de los mismos
CL2008002984A1 (es) Composicion farmaceutica que comprende micofenolato sodico y su uso para el tratamiento y/o prevencion en enfermedades autoinmunes tales como el rechazo de aloinjertos o xenoinjertos de organos, celulas o tejidos y como antiinflamatorio.
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
ECSP22016567A (es) Compuestos inhibidores de rip1 y m?todos para prepararlos y usarlos
BR112017018643A2 (pt) "derivados de tetra-hidrotiazepina bicíclicos úteis, composição farmacêutica compreendendo os mesmos, seu uso, e método in vitro ou ex vivo para a produção de células imunes ativadas"
AR083249A1 (es) Combinaciones sinergicas de triazoles, estrobirulinas y benzimidazoles, usos, formulaciones, procedimientos de produccion y aplicaciones utilizando las mismas
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
BR112019010128A2 (pt) proteínas de ligação a antígeno anti-gitr e métodos de uso das mesmas
CO2020003475A2 (es) Sulfonas y sulfóxidos bicíclicos y métodos de uso de los mismos
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
UY29417A1 (es) Agentes endoparasiticidas
UY32975A (es) Derivados de aminopiridina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CONVATEC, INC (US)